RESEARCH BASE
Search 3,721 documents across 34 fields — every claim tier-rated by evidence
3,633 are the core, quality-scored corpus (34 lettered sections — see How We Work); the remaining 88 are cross-corpus synthesis documents (68 InterDocs, 12 Connections, 8 Theories) also indexed here.
1,517 results for "reductio ad absurdum" — page 32 of 76
Z_3_03 — Ancient Pathogen Genomics — Plague, TB, Smallpox DNA
Ancient pathogen genomics — the recovery and sequencing of disease-causing organism DNA from archaeological remains — has revolutionized understanding of human disease history. Beginning with the landmark reconstruction
Z_3_12 — Genetics of Alcohol Metabolism
The genetics of alcohol metabolism provides one of the clearest examples of how specific genetic variants influence behavior and disease risk at a population scale. Ethanol is metabolized primarily through a two-step oxi
Z_3_04 — Comparative Genomics and Cross-Species Analysis
Comparative genomics — the systematic comparison of genome sequences across species — has become the primary tool for understanding genome evolution, identifying functionally important sequences, and reconstructing the T
Z_3_11 — Genetic Mosaicism and Chimerism
A fundamental assumption of genetics — that every cell in an individual's body carries the same genome — is wrong. Genetic mosaicism (the presence of two or more genetically distinct cell populations within an individual
Z_3_01 — Genetics of Brain Development — ASPM, Microcephalin, HAR1
The human brain is approximately three times larger than expected for a primate of our body size, with a vastly expanded cerebral cortex containing ~86 billion neurons. Identifying the genetic basis for this extraordinar
Z_2_13 — Pharmacogenomics and Personalized Medicine
Pharmacogenomics — the study of how genetic variation influences drug response — is among the most clinically actionable applications of human genetics. Adverse drug reactions (ADRs) are the 4th–6th leading cause of deat
Z_2_03 — Pharmacogenomics & Ethnobotanical Genetics
Pharmacogenomics — the study of how genetic variation affects drug response — has revealed that enzymes governing drug metabolism, particularly the cytochrome P450 (CYP) superfamily, show extraordinary population-specifi
Z_2_08 — Prion Genetics and Misfolded Proteins
Prions are infectious agents composed entirely of misfolded protein — the only known pathogen that contains no nucleic acid (no DNA, no RNA). The protein-only hypothesis (Stanley Prusiner, 1982 — Nobel Prize 1997) states
Z_2_17 — Prion Biology: Self-Propagating Protein Misfolding and Transmissible Encephalopathies
Prions — proteinaceous infectious particles lacking nucleic acid — represent a paradigm-shattering departure from the central dogma that biological information flows from DNA to RNA to protein. The protein-only hypothesi
Z_2_18 — Pharmacogenomics and Precision Medicine
Pharmacogenomics — the study of how genetic variation affects individual responses to drugs — aims to replace the "one-size-fits-all" prescribing model with genotype-guided therapy, selecting the right drug at the right
Z_2_06 — Nutrigenomics and Diet-Gene Interactions
Nutrigenomics — the study of how genetic variation influences nutritional requirements, dietary responses, and disease susceptibility — and its complement nutrigenetics (how diet influences gene expression) represent a r
Z_2_11 — Genetics of Immunity and MHC Diversity
The major histocompatibility complex (MHC) — known as the human leukocyte antigen (HLA) system in humans — is the most polymorphic gene region in the human genome, encoding cell-surface glycoproteins essential for adapti
Z_2_07 — Genetics of Disease Resistance
Infectious disease has been the most powerful selective force shaping the human genome, leaving signatures across thousands of loci. The best-understood example is sickle cell disease (HbS, Glu6Val in HBB): heterozygous
Z_2_05 — Gene Therapy: History and Progress
Gene therapy — the introduction, alteration, or replacement of genetic material within a patient's cells to treat or cure disease — has evolved from a speculative concept to an approved clinical reality over five decades
Z_2_23 — Immune System & Immunology
The immune system is a multi-layered defense network that protects organisms against pathogens including bacteria, viruses, fungi, and parasites. It comprises two interconnected arms: innate immunity, which provides rapi
Z_2_01 — HLA System & Archaic Immune Inheritance
The Human Leukocyte Antigen (HLA) system is the most polymorphic region of the human genome, encoding cell-surface proteins critical to adaptive immune function. Located on chromosome 6p21.3, the Major Histocompatibility
Z_1_18 — Junk DNA & the ENCODE Controversy: Function, Noise, and the Human Genome
The term "junk DNA" — coined by Susumu Ohno (1972) to describe non-coding DNA sequences in eukaryotic genomes that appeared to have no functional role — ignited one of the most contentious debates in modern genomics: how
Z_1_05 — Genomic Imprinting and Parent-of-Origin Effects
Genomic imprinting is an epigenetic phenomenon in which a gene's expression depends on whether it was inherited from the mother or the father — violating the standard Mendelian assumption that both parental copies functi
Z_1_12 — Genome Architecture and 3D Organization
The human genome — approximately 6.4 billion base pairs of DNA — is packed into a nucleus only ~6 μm in diameter. If stretched end-to-end, the DNA of a single human cell would extend about 2 meters, yet it is packaged an
Z_4_18 — Protein Misfolding and Prion Diseases
Prion diseases — transmissible spongiform encephalopathies (TSEs) — are fatal neurodegenerative disorders caused by the misfolding and self-propagating aggregation of a normal cellular protein (PrPᶜ) into a pathological
BROWSE BY SECTION — 3,721 documents across 34 fields